论文部分内容阅读
目前对于原发性肝癌(primary hepatic carcinoma,PHC)的诊断、疗效评估、复发及转移意义最大的是甲胎蛋白(AFP),但我国有30%-40%患者AFP为阴性,因此寻找AFP以外的PHC诊断、疗效观察及治疗后提示复发、转移的标志物成为近年研
At present, AFP is the most valuable diagnostic, therapeutic evaluation, recurrence and metastasis of primary hepatic carcinoma (PHC), but AFP is negative in 30% -40% of the patients in our country PHC diagnosis, observation and treatment of curative effect after recurrence, metastasis markers become recent years